The Jayhawks have added four top-100 transfers so far this offseason.
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S.
Steady Performance Amidst Challenging Economic Climate